DOCSLIB.ORG

Meta-Analysis of Mutations in ALOX12B Or ALOXE3 Identified in a Large Cohort of 224 Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meta-Analysis of Mutations in ALOX12B Or ALOXE3 Identified in a Large Cohort of 224 Patients University of Groningen Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients Hotz, Alrun; Kopp, Julia; Bourrat, Emmanuelle; Oji, Vinzenz; Komlosi, Katalin; Giehl, Kathrin; Bouadjar, Bakar; Bygum, Anette; Tantcheva-Poor, Iliana; Hellstrom Pigg, Maritta Published in: Genes DOI: 10.3390/genes12010080 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2021 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Hotz, A., Kopp, J., Bourrat, E., Oji, V., Komlosi, K., Giehl, K., Bouadjar, B., Bygum, A., Tantcheva-Poor, I., Hellstrom Pigg, M., Has, C., Yang, Z., Irvine, A. D., Betz, R. C., Zambruno, G., Tadini, G., Suessmuth, K., Gruber, R., Schmuth, M., ... Fischer, J. (2021). Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients. Genes, 12(1), [80]. https://doi.org/10.3390/genes12010080 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 27-09-2021 G C A T T A C G G C A T genes Article Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients Alrun Hotz 1 , Julia Kopp 1, Emmanuelle Bourrat 2, Vinzenz Oji 3, Katalin Komlosi 1, Kathrin Giehl 4, Bakar Bouadjar 5, Anette Bygum 6,7,8, Iliana Tantcheva-Poor 9, Maritta Hellström Pigg 10, Cristina Has 11, Zhou Yang 1,12, Alan D. Irvine 13, Regina C. Betz 14 , Giovanna Zambruno 15, Gianluca Tadini 16, Kira Süßmuth 3, Robert Gruber 17, Matthias Schmuth 17 , Juliette Mazereeuw-Hautier 18, Natalie Jonca 19, Sophie Guez 16, Michela Brena 16, Angela Hernandez-Martin 20, Peter van den Akker 21, Maria C. Bolling 22, Katariina Hannula-Jouppi 23,24, Andreas D. Zimmer 1 , Svenja Alter 1, Anders Vahlquist 25 and Judith Fischer 1,* 1 Institute of Human Genetics, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany; [email protected] (A.H.); [email protected] (J.K.); [email protected] (K.K.); [email protected] (Z.Y.); [email protected] (A.D.Z.); [email protected] (S.A.) 2 Department of Dermatology, Reference Center for Rare Skin Diseases MAGEC, Saint Louis Hospital AP-HP, 75010 Paris, France; [email protected] 3 Department of Dermatology and Venereology, Münster University Medical Center, 48149 Münster, Germany; [email protected] (V.O.); [email protected] (K.S.) 4 Department of Dermatology and Allergy, University of Munich LMU, 80337 Munich, Germany; [email protected] 5 Department of Dermatology, CHU of Bab-El-Oued Algiers, Algiers 16008, Algeria; [email protected] 6 Department of Dermatology, Odense University Hospital, 5000 Odense, Denmark; [email protected] 7 Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark 8 Clinical Institute, University of Southern Denmark, 5000 Odense, Denmark 9 Department of Dermatology, University of Cologne, 50937 Cologne, Germany; [email protected] Citation: Hotz, A.; Kopp, J.; Bourrat, 10 Department of Clinical Genetics, Karolinska University Hospital, 17176 Stockholm, Sweden; E.; Oji, V.; Komlosi, K.; Giehl, K.; [email protected] 11 Bouadjar, B.; Bygum, A.; Department of Dermatology, Medical Center-University of Freiburg, University of Freiburg, 79104 Freiburg, Tantcheva-Poor, I.; Hellström Pigg, Germany; [email protected] 12 Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, National Center for M.; et al. Meta-Analysis of Mutations Children’s Health, Beijing 100045, China in ALOX12B or ALOXE3 Identified in 13 Dermatology, Children’s Health Ireland and Clinical Medicine, Trinity College Dublin, D12 N512 Dublin, a Large Cohort of 224 Patients. Genes Ireland; [email protected] 2021, 12, 80. https://doi.org/ 14 Institute of Human Genetics, School of Medicine & University Hospital Bonn, University of Bonn, 10.3390/genes12010080 53127 Bonn, Germany; [email protected] 15 Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children’s Hospital, Received: 23 December 2020 IRCCS, 00165 Rome, Italy; [email protected] 16 Accepted: 6 January 2021 Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, UOSD Pediatria ad Alta Intensità di Cura, Published: 9 January 2021 20122 Milan, Italy; [email protected] (G.T.); [email protected] (S.G.); [email protected] (M.B.) 17 Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, 6020 Innsbruck, Publisher’s Note: MDPI stays neu- Austria; [email protected] (R.G.); [email protected] (M.S.) tral with regard to jurisdictional clai- 18 Reference Center for Rare Skin Diseases, Dermatology Department, CHU Larrey, Université Paul Sabatier, ms in published maps and institutio- 31000 Toulouse, France; [email protected] nal affiliations. 19 Department of Epidermis Differentiation and Rheumatoid Autoimmunity, UMR 1056 Inserm University Toulouse, Place du Dr Baylac, Hôpital Purpan, 31059 Toulouse, France; [email protected] 20 Department of Dermatology, Hospital Infantil Niño Jesús, 28009 Madrid, Spain; [email protected] 21 Department of Genetics, University Medical Center Groningen, University of Groningen, 9700RB Groningen, Copyright: © 2021 by the authors. Li- The Netherlands; [email protected] censee MDPI, Basel, Switzerland. 22 Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, This article is an open access article University of Groningen, 9700RB Groningen, The Netherlands; [email protected] 23 distributed under the terms and con- ERN-Skin Center, Department of Dermatology and Allergology, University of Helsinki and Helsinki University Central Hospital, 00029 HUS Helsinki, Finland; Katariina.Hannula-Jouppi@hus.fi ditions of the Creative Commons At- 24 Folkhälsan Research Center, Helsinki, Finland and Research Programs Unit, Stem Cells and Metabolism tribution (CC BY) license (https:// Research Program, University of Helsinki, 00290 Helsinki, Finland creativecommons.org/licenses/by/ 4.0/). Genes 2021, 12, 80. https://doi.org/10.3390/genes12010080 https://www.mdpi.com/journal/genes Genes 2021, 12, 80 2 of 11 25 Department of Medical Sciences/Dermatology, Uppsala University, SE-751 85 Uppsala, Sweden; [email protected] * Correspondence: judith.fi[email protected] Abstract: The autosomal recessive congenital ichthyoses (ARCI) are a nonsyndromic group of cornification disorders that includes lamellar ichthyosis, congenital ichthyosiform erythroderma, and harlequin ichthyosis. To date mutations in ten genes have been identified to cause ARCI: TGM1, ALOX12B, ALOXE3, NIPAL4, CYP4F22, ABCA12, PNPLA1, CERS3, SDR9C7, and SULT2B1. The main focus of this report is the mutational spectrum of the genes ALOX12B and ALOXE3, which encode the epidermal lipoxygenases arachidonate 12-lipoxygenase, i.e., 12R type (12R-LOX), and the epidermis-type lipoxygenase-3 (eLOX3), respectively. Deficiency of 12R-LOX and eLOX3 disrupts the epidermal barrier function and leads to an abnormal epidermal differentiation. The type and the position of the mutations may influence the ARCI phenotype; most patients present with a mild erythrodermic ichthyosis, and only few individuals show severe erythroderma. To date, 88 pathogenic mutations in ALOX12B and 27 pathogenic mutations in ALOXE3 have been reported in the literature. Here, we presented a large cohort of 224 genetically characterized ARCI patients who carried mutations in these genes. We added 74 novel mutations in ALOX12B and 25 novel mutations in ALOXE3. We investigated the spectrum of mutations in ALOX12B and ALOXE3 in our cohort and additionally in the published mutations, the distribution of these mutations within the gene and gene domains, and potential hotspots and recurrent mutations. Keywords: ALOX12B; ALOXE3; ARCI; ichthyosis 1. Introduction Autosomal recessive congenital ichthyosis (ARCI) comprises a clinically and genet- ically heterogeneous group of rare disorders of cornification characterized by hyperker- atosis, scaling of the body, and a variable degree of erythroderma. ARCI is subclassified into lamellar ichthyosis (LI), congenital ichthyosiform erythroderma (CIE), and harlequin ichthyosis (HI). Patients with LI often present with large, dark plate-like scales and with minimal erythema, whereas patients with CIE usually show variable erythroderma and generalized fine white scaling. Some patients show overlapping phenotypes of LI and CIE. HI represents the most severe form of ARCI and is a potentially life-threatening condition. CIE is typically on the milder
Load more

Recommended publications
  • Eicosanoids in Carcinogenesis
    4open 2019, 2,9 © B.L.D.M. Brücher and I.S. Jamall, Published by EDP Sciences 2019 https://doi.org/10.1051/fopen/2018008 Special issue: Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer” Available online at: Guest Editor: Obul R. Bandapalli www.4open-sciences.org REVIEW ARTICLE Eicosanoids in carcinogenesis Björn L.D.M. Brücher1,2,3,*, Ijaz S. Jamall1,2,4 1 Theodor-Billroth-Academy®, Germany, USA 2 INCORE, International Consortium of Research Excellence of the Theodor-Billroth-Academy®, Germany, USA 3 Department of Surgery, Carl-Thiem-Klinikum, Cottbus, Germany 4 Risk-Based Decisions Inc., Sacramento, CA, USA Received 21 March 2018, Accepted 16 December 2018 Abstract- - Inflammation is the body’s reaction to pathogenic (biological or chemical) stimuli and covers a burgeoning list of compounds and pathways that act in concert to maintain the health of the organism. Eicosanoids and related fatty acid derivatives can be formed from arachidonic acid and other polyenoic fatty acids via the cyclooxygenase and lipoxygenase pathways generating a variety of pro- and anti-inflammatory mediators, such as prostaglandins, leukotrienes, lipoxins, resolvins and others. The cytochrome P450 pathway leads to the formation of hydroxy fatty acids, such as 20-hydroxyeicosatetraenoic acid, and epoxy eicosanoids. Free radical reactions induced by reactive oxygen and/or nitrogen free radical species lead to oxygenated lipids such as isoprostanes or isolevuglandins which also exhibit pro-inflammatory activities. Eicosanoids and their metabolites play fundamental endocrine, autocrine and paracrine roles in both physiological and pathological signaling in various diseases. These molecules induce various unsaturated fatty acid dependent signaling pathways that influence crosstalk, alter cell–cell interactions, and result in a wide spectrum of cellular dysfunctions including those of the tissue microenvironment.
    [Show full text]
  • Homozygous ALOXE3 Nonsense Variant Identified in a Patient With
    Int. J. Mol. Sci. 2015, 16, 21791-21801; doi:10.3390/ijms160921791 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Homozygous ALOXE3 Nonsense Variant Identified in a Patient with Non-Bullous Congenital Ichthyosiform Erythroderma Complicated by Superimposed Bullous Majocchi’s Granuloma: The Consequences of Skin Barrier Dysfunction Tao Wang 1, Chenchen Xu 1, Xiping Zhou 1, Chunjia Li 2, Hongbing Zhang 2, Bill Q. Lian 3, Jonathan J. Lee 4, Jun Shen 4, Yuehua Liu 1,* and Christine Guo Lian 4,* 1 Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100730, China; E-Mails: [email protected] (T.W.); [email protected] (C.X.); [email protected] (X.Z.) 2 State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; E-Mails: [email protected] (C.L.); [email protected] (H.Z.) 3 Department of Medicine, University of Massachusetts, Worcester, MA 01655, USA; E-Mail: [email protected] 4 Department of Pathology, Brigham & Women’s Hospital, Harvard Medical School, 221 Longwood Ave. EBRC 401, Boston, MA 02115, USA; E-Mails: [email protected] (J.J.L.); [email protected] (J.S.) † These authors contributed equally to this work. * Authors to whom correspondence should be addressed; E-Mails: [email protected] (Y.L.); [email protected] (C.G.L.); Tel./Fax: +86-10-6916-1502 (Y.L.).
    [Show full text]
  • A Mouse Mutation in the 12R-Lipoxygenase, Alox12b, Disrupts Formation of the Epidermal Permeability Barrier Jennifer L
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector ORIGINAL ARTICLE A Mouse Mutation in the 12R-Lipoxygenase, Alox12b, Disrupts Formation of the Epidermal Permeability Barrier Jennifer L. Moran1, Haiyan Qiu1, Annick Turbe-Doan1, Yujuan Yun1, William E. Boeglin2, Alan R. Brash2 and David R. Beier1 Nonbullous congenital ichthyosiform erythroderma (NCIE) is a nonsyndromic form of autosomal recessive congenital ichthyosis characterized by hyperkeratosis and a disruption in the epidermal permeability barrier. Identification of mutations in two lipoxygenases (LOXs), ALOX12B (12R-LOX) and ALOXE3 (eLOX3), and further functional studies implicate ALOX12B and ALOXE3 in the etiology of NCIE. Here, we report a mutation in Alox12b in the recessive ethylnitrosurea-induced mouse mutant, mummy (Alox12bmmy-Bei). mummy mutants have red, scaly skin and die perinatally. Histologically, mummy mutants display defects in the epidermis. We mapped mummy to a 1.9 Mb interval on Chr. 11 containing Alox12b (12R-LOX), Aloxe3 (eLOX3) and Alox15b (8-LOX). Sequencing of all three genes identified a nonsense mutation in the catalytic domain of Alox12b.We demonstrate that mummy mutants have a disrupted epidermal permeability barrier and that the nonsense mutation in mummy abolishes the enzyme activity of 12R-LOX. The mummy mutant provides a mouse model for LOX-mediated NCIE and is the first described mouse mutant affecting epidermal barrier formation identified by forward genetics. Journal of Investigative Dermatology (2007) 127, 1893–1897; doi:10.1038/sj.jid.5700825; published online 12 April 2007 INTRODUCTION of two types: lamellar ichthyosis (LI) and nonbullous The epidermal permeability barrier is a specialized epidermal congenital ichthyosiform erythroderma (NCIE, CIE, or NBCIE) structure that protects the skin from dehydration and the entry (reviewed in Akiyama et al., 2003).
    [Show full text]
  • Essential Role of the Cytochrome P450 CYP4F22 in the Production of Acylceramide, the Key Lipid for Skin Permeability Barrier Formation
    Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation Yusuke Ohnoa, Shota Nakamichia, Aya Ohkunia, Nozomi Kamiyamaa, Ayano Naoeb, Hisashi Tsujimurab, Urara Yokoseb, Kazumitsu Sugiurac, Junko Ishikawab, Masashi Akiyamac, and Akio Kiharaa,1 aLaboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo 060-0812, Japan; bKao Corporation, Haga-gun, Tochigi 321-3497, Japan; and cDepartment of Dermatology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan Edited by David W. Russell, University of Texas Southwestern Medical Center, Dallas, TX, and approved May 21, 2015 (received for review February 19, 2015) A skin permeability barrier is essential for terrestrial animals, and its lamellae and/or to stabilize the multiple lipid layers. Linoleic impairment causes several cutaneous disorders such as ichthyosis and acid is one of the essential FAs, and its deficiency causes ich- atopic dermatitis. Although acylceramide is an important lipid for the thyosis symptoms resulting from a failure to form normal acyl- skin permeability barrier, details of its production have yet to be de- ceramide (8). Ichthyosis is a cutaneous disorder accompanied termined, leaving the molecular mechanism of skin permeability bar- by dry, thickened, and scaly skin; it is caused by a barrier ab- rier formation unclear. Here we identified the cytochrome P450 gene normality. In patients who have atopic dermatitis, both total CYP4F22 (cytochrome P450, family 4, subfamily F, polypeptide 22) as ceramide levels and the chain length of ceramides are de- the long-sought fatty acid ω-hydroxylase gene required for acylcer- creased, and ceramide composition is altered also (9–11).
    [Show full text]
  • Identification of a Novel Enzyme from E. Pacifica That Acts As an Eicosapentaenoic 8R-LOX and Docosahexaenoic 10R-LOX
    www.nature.com/scientificreports OPEN Identifcation of a novel enzyme from E. pacifca that acts as an eicosapentaenoic 8R‑LOX and docosahexaenoic 10R‑LOX Sayaka Yuki1,5, Aiko Uemura1, Mayuka Hakozaki1, Akira Yano1, Masato Abe2, Yoshihisa Misawa3, Naomichi Baba3 & Hidetoshi Yamada1,4,5* North Pacifc krill (Euphausia pacifca) contain 8R‑hydroxy‑eicosapentaenoic acid (8R‑HEPE), 8R‑hydroxy‑eicosatetraenoic acid (8R‑HETE) and 10R‑hydroxy‑docosahexaenoic acid (10R‑HDHA). These fndings indicate that E. pacifca must possess an R type lipoxygenase, although no such enzyme has been identifed in krill. We analyzed E. pacifca cDNA sequence using next generation sequencing and identifed two lipoxygenase genes (PK-LOX1 and 2). PK-LOX1 and PK-LOX2 encode proteins of 691 and 686 amino acids, respectively. Recombinant PK‑LOX1 was generated in Sf9 cells using a baculovirus expression system. PK‑LOX1 metabolizes eicosapentaenoic acid (EPA) to 8R‑HEPE, arachidonic acid (ARA) to 8R‑HETE and docosahexaenoic acid (DHA) to 10R‑HDHA. Moreover, PK‑LOX1 had higher activity for EPA than ARA and DHA. In addition, PK‑LOX1 also metabolizes 17S‑HDHA to 10R,17S‑dihydroxy‑docosahexaenoic acid (10R,17S‑DiHDHA). PK‑LOX1 is a novel lipoxygenase that acts as an 8R‑lipoxygenase for EPA and 10R‑lipoxygenase for DHA and 17S‑HDHA. Our fndings show PK‑LOX1 facilitates the enzymatic production of hydroxy fatty acids, which are of value to the healthcare sector. Abbreviations LOX Lipoxygenase EPA Eicosapentaenoic acid DHA Docosahexaenoic acid ARA​ Arachidonic acid HEPE Hydroxy-eicosapentaenoic acid HDHA Hydroxy-docosahexaenoic acid HETE Hydroxy-eicosatetraenoic acid MeOH Methanol PUFA Polyunsaturated fatty acid LC/QTOFMS Liquid chromatography/hybrid quadrupole time-of-fight mass spectrometry Lipoxygenases (LOXs) are non-heme iron-containing dioxygenases that catalyze the dioxygenation of polyun- saturated fatty acids (PUFAs)1–4.
    [Show full text]
  • Regulation of Tissue Inflammation by 12-Lipoxygenases
    biomolecules Review Regulation of Tissue Inflammation by 12-Lipoxygenases Abhishek Kulkarni 1 , Jerry L. Nadler 2, Raghavendra G. Mirmira 1,* and Isabel Casimiro 1,* 1 Department of Medicine, The University of Chicago, Chicago, IL 60637, USA; [email protected] 2 Department of Medicine and Pharmacology, New York Medical College, Valhalla, NY 10595, USA; [email protected] * Correspondence: [email protected] (R.G.M.); [email protected] (I.C.) Abstract: Lipoxygenases (LOXs) are lipid metabolizing enzymes that catalyze the di-oxygenation of polyunsaturated fatty acids to generate active eicosanoid products. 12-lipoxygenases (12-LOXs) primarily oxygenate the 12th carbon of its substrates. Many studies have demonstrated that 12-LOXs and their eicosanoid metabolite 12-hydroxyeicosatetraenoate (12-HETE), have significant pathological implications in inflammatory diseases. Increased level of 12-LOX activity promotes stress (both oxidative and endoplasmic reticulum)-mediated inflammation, leading to damage in these tissues. 12-LOXs are also associated with enhanced cellular migration of immune cells—a characteristic of several metabolic and autoimmune disorders. Genetic depletion or pharmacological inhibition of the enzyme in animal models of various diseases has shown to be protective against disease development and/or progression in animal models in the setting of diabetes, pulmonary, cardiovascular, and metabolic disease, suggesting a translational potential of targeting the enzyme for the treatment of several disorders. In this article, we review the role of 12-LOXs in the pathogenesis of several diseases in which chronic inflammation plays an underlying role. Citation: Kulkarni, A.; Nadler, J.L.; Keywords: 12-lipoxygenases; 12-LOXs; 12/15-lipoxygenase; 12/15-LOX; lipoxygenases; eicosanoids; Mirmira, R.G.; Casimiro, I.
    [Show full text]
  • Original Article Genetic Variants of Aloxs Genes in Polyunsaturated Fatty Acid/Arachidonic Acid Metabolism Associated with Type-2 Diabetes Development
    Int J Clin Exp Med 2018;11(12):13797-13805 www.ijcem.com /ISSN:1940-5901/IJCEM0077987 Original Article Genetic variants of ALOXs genes in polyunsaturated fatty acid/arachidonic acid metabolism associated with type-2 diabetes development Jim Jinn-Chyuan Sheu1,3,4,5*, Ying-Ju Lin1,3*, Cherry Yin-Yi Chang2, Shih-Yin Chen1,3, Wen-Ling Liao1,4, Jai-Sing Yang1, Ming-Tsung Lai6, Chih-Mei Chen1, Chun-Cheng Tseng4, Tritium Hwang4, Ping-Ho Chen7, Fuu-Jen Tsai1,3 1Human Genetic Center, 2Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan; 3School of Chinese Medicine, China Medical University, Taichung, Taiwan; 4Institute of Biomedical Sci- ences, National Sun Yat-sen University, Kaohsiung, Taiwan; 5Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan; 6Department of Pathology, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; 7School of Dentistry, Kaohsiung Medical University, Kaohsiung, Taiwan. *Equal contributors. Received April 16, 2018; Accepted July 24, 2018; Epub December 15, 2018; Published December 30, 2018 Abstract: Poly-unsaturated fatty acids (PUFAs)/arachidonic acids (AAs) and their derived eicosanoids play potent roles in triggering inflammation during obesity and diabetes development. Recent studies have indicated functional roles of ALOX5, ALOX12, ALOX12B, and ALOX15 in the development of insulin resistance and islet β-cell dysfunc- tion. However, the impact of their genetic variants on type 2 diabetes (T2D) development in Asian patients remains unclear. In this study, 1,682 healthy controls and 788 patients with T2D were enrolled for genotyping those four ALOX genes by the TaqMan method. A total of eight Han Chinese-specific SNPs (two SNps for each gene) were selected for this study.
    [Show full text]
  • Functional Characterization of Genetic Enzyme Variations in Human Lipoxygenases
    Redox Biology 1 (2013) 566–577 Contents lists available at ScienceDirect Redox Biology journal homepage: www.elsevier.com/locate/redox Functional characterization of genetic enzyme variations in human lipoxygenases Thomas Horn a,n, Kumar Reddy Kakularam b, Monika Anton a, Constanze Richter c, Pallu Reddanna b,d, Hartmut Kuhn a a Institute of Biochemistry, University Medicine Berlin—Charité, Charitéplatz 1, D-10117 Berlin, Germany b Department of Animal Sciences, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad 500046, Andhra Pradesh, India c Institute of Nutrition Technology and Nutrition Chemistry, TU Berlin, Gustav-Meyer-Allee 25, D-13355 Berlin, Germany d National Institute of Animal Biotechnology, Hyderabad 500046, Andhra Pradesh, India article info abstract Article history: Mammalian lipoxygenases play a role in normal cell development and differentiation but they have also been Received 28 October 2013 implicated in the pathogenesis of cardiovascular, hyperproliferative and neurodegenerative diseases. As lipid Accepted 1 November 2013 peroxidizing enzymes they are involved in the regulation of cellular redox homeostasis since they produce lipid hydroperoxides, which serve as an efficient source for free radicals. There are various epidemiological Keywords: correlation studies relating naturally occurring variationsinthesixhumanlipoxygenasegenes(SNPsorrare Eicosanoids mutations) to the frequency for various diseases in these individuals, but for most of the described variations no Leukotrienes functional data are available. Employing a combined bioinformatical and enzymological strategy, which Lipoxygenases included structural modeling and experimental site-directed mutagenesis, we systematically explored the Gene polymorphism structural and functional consequences of non-synonymous genetic variations in four different human SNP lipoxygenase genes (ALOX5, ALOX12, ALOX15, and ALOX15B) that have been identified in the human 1000 genome project.
    [Show full text]
  • Aloxe3 (NM 011786) Mouse Tagged ORF Clone – MR225887L4 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for MR225887L4 Aloxe3 (NM_011786) Mouse Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Aloxe3 (NM_011786) Mouse Tagged ORF Clone Tag: mGFP Symbol: Aloxe3 Synonyms: e-LOX-3; eLOX-3 Vector: pLenti-C-mGFP-P2A-Puro (PS100093) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(MR225887). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_011786 ORF Size: 2136 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Aloxe3 (NM_011786) Mouse Tagged ORF Clone – MR225887L4 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_011786.2, NP_035916.2 RefSeq Size: 2538 bp RefSeq ORF: 2136 bp Locus ID: 23801 UniProt ID: Q14B96, Q9WV07 Gene Summary: Non-heme iron-containing lipoxygenase which is atypical in that it displays a prominent hydroperoxide isomerase activity and a reduced dioxygenase activity compared to other lipoxygenases.
    [Show full text]
  • Aloxe3 (NM 001105793) Rat Untagged Clone – RN213879 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RN213879 Aloxe3 (NM_001105793) Rat Untagged Clone Product data: Product Type: Expression Plasmids Product Name: Aloxe3 (NM_001105793) Rat Untagged Clone Tag: Tag Free Symbol: Aloxe3 Synonyms: e-LOX-3; eLOX-3 Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 Aloxe3 (NM_001105793) Rat Untagged Clone – RN213879 Fully Sequenced ORF: >RN213879 representing NM_001105793 Red=Cloning site Blue=ORF Orange=Stop codon TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGCAGTATATCGCCTGTGTGTGACCACTGGTTCCTACCTGAAGGCTGGCACATTGGATAACATCTATG CTACACTGGTAGGCACCTGTGGTGAAAGCCCTAAGCAGAAGCTGGATCGTGTAGGCAGGGACTTCGCCAC CGGATCGGTTCAGAAGTACAAGGTGCGCTGTGCATCAGAGCTGGGTGAGATCTTGCTGTTGCGCTTACAC AAGGAGCGCTTTGCTTTCTTCTGCAAGGATCCTTGGTACTGCAGTCGCATCTGTGTCACTACCCCAGATG GCTCTGTGGTTCACTTTCCCTGTTATCAGTGGATCGATGGCTACTGTACTGTGGAGCTTCGGCCAGGAAC AGCAAGAACCATCTGCCAGGATGCTCTTCCCCTCCTTCTGGATCACAGGAAGCGTGAACTCCAAGCCCGC CAAGAATGCTACCGCTGGAAGATCTATGCCCCTGGTTTCCCTCGAATGGTGGATGTCAGCAGCTTTGAGG AGATGGAGTCAGATAAGAAATTTGCCTTGACCAAGACGGCGCCTTGTGCAGACCAGGATGATAACTCTGG GAACCGGTACCTGCCTGGCTTTCCTATGAAAGTTGACATCCCATCTCTGCTGCACATGGAGCCCAACATT
    [Show full text]
  • Product Datasheet ALOX12B Antibody H00000242-A01
    Product Datasheet ALOX12B Antibody H00000242-A01 Unit Size: 0.05 ml Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. Publications: 5 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/H00000242-A01 Updated 2/5/2017 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/H00000242-A01 Page 1 of 3 v.20.1 Updated 2/5/2017 H00000242-A01 ALOX12B Antibody Product Information Unit Size 0.05 ml Concentration This product is unpurified. The exact concentration of antibody is not quantifiable. Storage Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. Clonality Polyclonal Preservative No Preservative Purity Unpurified Buffer Unpurified antisera so the specific antibody concentration is unknown. Contains 50% glycerol. Product Description Host Mouse Gene ID 242 Gene Symbol ALOX12B Species Human Reactivity Notes Other species not tested. Specificity/Sensitivity ALOX12B - arachidonate 12-lipoxygenase, 12R type Immunogen ALOX12B (NP_001130, 171 a.a. ~ 262 a.a) partial recombinant protein with GST tag.NPNRPEWNGYIPGFPILINFKATKFLNLNLRYSFLKTASFFVRLGPMALAFKV RGLLDCKHSWKRLKDIRKIFPGKKSVVSEYVAEHWAED Notes This product is produced by and distributed for Abnova, a company based in Taiwan. Product Application Details Applications Western Blot, ELISA Recommended Dilutions Western Blot 1:500, ELISA 1:100-1:2000 Application Notes Antibody reactive against cell lysate and recombinant protein for western blot. It has also been used for ELISA. Images Western Blot: ALOX12B Antibody [H00000242-A01] - Analysis of ALOX12B expression in Jurkat (Cat # L017V1). Page 2 of 3 v.20.1 Updated 2/5/2017 Publications Nigam S, Zafiriou MP, Deva R et al.
    [Show full text]
  • The Role of the Second 15-Lipoxygenase, ALOX15B, in Atherosclerosis: a Genetic Approach
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 The Role of the Second 15-Lipoxygenase, ALOX15B, in Atherosclerosis: a Genetic Approach Wüst, Sophia Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-92378 Dissertation Published Version Originally published at: Wüst, Sophia. The Role of the Second 15-Lipoxygenase, ALOX15B, in Atherosclerosis: a Genetic Ap- proach. 2013, University of Zurich, Faculty of Medicine. The Role of the Second 15-Lipoxygenase, ALOX15B, in Atherosclerosis: a Genetic Approach Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr.sc.nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Sophia Julia Annette Wüst von Oberriet-Montlingen SG Promotionskomitee Prof. Dr. Thierry Hennet Prof. Dr. Martin Hersberger (Leitung der Dissertation) Prof. Dr. Arnold von Eckardstein Zürich, 2014 CONTENTS CONTENTS ..............................................................................................1 ABBREVIATIONS.....................................................................................3 SUMMARY................................................................................................6 ZUSAMMENFASSUNG............................................................................8 1. INTRODUCTION ................................................................................10 1.1 Atherosclerosis .................................................................................10
    [Show full text]